{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:45:56Z","timestamp":1783035956061,"version":"3.54.6"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) is a heterogeneous autoimmune disease in which interstitial lung disease (ILD) is a major determinant of mortality. Given that certain chemokines and adhesion molecules may be involved in the inflammation, subsequent vascular injury, and fibrosis observed in SSc, their circulating levels in peripheral blood may reflect the disease processes ranging from inflammation to vascular damage and fibrotic remodeling. However, the potential of these biomarkers to identify patient subgroups with divergent pulmonary trajectories remains to be elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of prospectively collected data from patients with early severe SSc (diffuse cutaneous SSc irrespective of ILD status or limited cutaneous SSc with ILD; disease duration &amp;lt;5 years) who were enrolled in a multicenter cohort. Serum levels of five chemokines and four soluble adhesion molecules were quantified at baseline. Patients were classified based on these biomarker profiles using k-means clustering. Changes in pulmonary function were compared among clusters using relative changes in percent vital capacity (%VC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients (n = 92) were classified into three clusters: Cluster 1 (n = 37) with elevated sICAM-1 and sE-selectin; Cluster 2 (n = 13) with elevated CCL2, CXCL8, and sP-selectin; and Cluster 3 (n = 42) with no distinctive biomarker pattern. Cluster 3 showed stable %VC and served as the reference group. Cluster 1 showed early decline (one-year difference: \u22128.41%; 95% CI: \u221212.62 to \u22124.20;\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u00a00.001) that attenuated by year two. In contrast, Cluster 2 showed progressive decline (two-year difference: \u22127.77%; 95% CI: \u221215.25 to \u22120.29;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.042). These biomarker-defined patterns were consistent with a vasculopathic\u2013fibrotic profile in Cluster 1 and an inflammatory\u2013vascular profile in Cluster 2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum chemokine and adhesion molecule profiles may help stratify early severe SSc into biologically distinct subgroups with different pulmonary trajectories, supporting their potential utility for early risk stratification in SSc-ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1798420","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:24Z","timestamp":1776662724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarker-based clustering identifies distinct pulmonary function trajectories in early systemic sclerosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Saori","family":"Uesugi-Uchida","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tohoku University Graduate School of Medicine","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirahito","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Southern Tohoku General Hospital","place":["Fukushima, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Ibaraki Prefectural Central Hospital and Cancer Center","place":["Ibaraki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Jinnin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wakayama Medical University Graduate School of Medicine","place":["Wakayama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Tokyo Women\u2019s Medical University","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences","place":["Nagasaki, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kitasato University Medical Center","place":["Kitamoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunari","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University","place":["Kumamoto, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University","place":["Ishikawa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei-ichiro","family":"Motegi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Gunma University Graduate School of Medicine","place":["Gunma, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayakazu","family":"Sumida","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Tokyo Graduate School of Medicine","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ueda-Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Osaka Graduate School of Medicine","place":["Suita, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"B2","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf100","article-title":"Comment on: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis: reply","volume":"64","author":"Gerges","year":"2025","journal-title":"Rheumatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438302","article-title":"Circulating cell adhesion molecules in systemic sclerosis: a systematic review and meta-analysis","volume":"15","author":"Mangoni","year":"2024","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1136\/thorax-2022-219226","article-title":"Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses","volume":"78","author":"Fields","year":"2023","journal-title":"Thorax"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000827","article-title":"Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment","volume":"33","author":"Arron","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1784548","article-title":"Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan","volume":"31","author":"Kuwana","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker333","article-title":"Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study","volume":"51","author":"Hasegawa","year":"2012","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41467-023-44645-6","article-title":"Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis","volume":"15","author":"Ma","year":"2024","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17403","article-title":"Predictors of clinical features in early\u2010onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort","volume":"51","author":"Uesugi\u2010Uchida","year":"2024","journal-title":"J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0795-6","article-title":"Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study","volume":"23","author":"Hasegawa","year":"2012","journal-title":"Mod Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088150","article-title":"Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study","volume":"9","author":"Hasegawa","year":"2014","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/9781444315844.ch12","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-31407-5_37","article-title":"Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis","volume":"30","author":"Kuwana","year":"2003","journal-title":"J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ins.2022.11.139","article-title":"K-means clustering algorithms: A comprehensive review, variants analysis, and advances in the era of big data","volume":"622","author":"Ikotun","year":"2023","journal-title":"Inf Sci (N Y)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: How CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.40171","article-title":"CCL2 in the circulation predicts long\u2010term progression of interstitial lung disease in patients with early systemic sclerosis: Data from two independent cohorts","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0364OC","article-title":"Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis","volume":"40","author":"Russo","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.03.015","article-title":"Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis","volume":"107","author":"Hesselstrand","year":"2013","journal-title":"Respir Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/168724","article-title":"Association between clinical features and course of systemic sclerosis and serum interleukin-8, vascular endothelial growth factor, basic fibroblast growth factor, and interferon alpha","volume":"33","author":"Kosa\u0142ka-W\u0119giel","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/all.15073","article-title":"Patients with systemic sclerosis show phenotypic and functional defects in neutrophils","volume":"77","author":"Impellizzieri","year":"2022","journal-title":"Allergy"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400135","article-title":"ICAM-1: isoforms and phenotypes","volume":"192","author":"Ramos","year":"2014","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512518","article-title":"E-Selectin, ICAM-1, and ET-1 biomarkers address the concern of the challenging diagnosis of interstitial lung disease in patients with autoimmune diseases","volume":"24","author":"Pulito-Cueto","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/art.42491","article-title":"A composite serum biomarker index for the diagnosis of systemic sclerosis\u2013associated interstitial lung disease: A multicenter, observational cohort study","volume":"75","author":"Jee","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221084845","article-title":"Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy","volume":"14","author":"Santana-Gon\u00e7alves","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1798420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T05:25:26Z","timestamp":1776662726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1798420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1798420"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1798420","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1798420"}}